Zantac is the popular brand name of a drug called Ranitidine, a type of medication with histamine-2 blockers, which is widely used to treat various gastrointestinal conditions such as heartburn and acid reflux. Zantac was first sold in the U.S. back in 1983 and quickly became one of the most widely used drugs on the market.
On Oct. 18, 2019, manufacturer Sanofi announced a voluntary recall of Zantac due to it containing N-Nitrosodimethylamine (NDMA), which may cause cancer in humans. Potential injuries to people who have used Zantac to treat heartburn may include cancers of the stomach, bladder, kidney, pancreatic, colon, liver, esophagus, lung or breast.
When you contact us via email, website form, or phone call, our attorneys will gather some information from you. An initial call is always free.
By submitting this form, I agree that Medlin Prince & Ramezanian may collect my information and use it to provide legal guidance and assistance. Your information will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever without your consent other than for the express purpose of delivering the service requested.
